22 March 2023 - Medicines Australia acknowledges the Health Technology Assessment Review Terms of Reference – released today – and ...
22 March 2023 - The terms of reference for the Health Technology Assessment Policy and Methods Review is now available. ...
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023. ...
10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023. ...
20 January 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee held its first two meetings on 1 ...
20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...
18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...
27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming ...
27 October 2022 - Medicines Australia welcomes the appointment of Adjunct Professor Debora Picone AO as independent Chair of the ...
27 October 2022 - On 6 September 2021, the Commonwealth entered into a new Strategic Agreement in relation to reimbursement, ...
27 October 2022 - The Government today announced the appointment of Adjunct Professor Debora Picone AO as Chair of the Health ...
26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...
5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...
22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...